Financhill
Sell
20

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.59
Seasonality move :
36.97%
Day range:
$0.59 - $0.61
52-week range:
$0.47 - $2.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.85x
P/B ratio:
1.93x
Volume:
3.1M
Avg. volume:
2.7M
1-year change:
37.05%
Market cap:
$154.8M
Revenue:
$60.3M
EPS (TTM):
-$0.18

Earnings Data

Next earnings date for ADAP
Mar 06
2025
Most recent earnings per share
-$0.06
Beat by $0.12
(Nov 13/2024)
Consensus Estimate
-$0.18
(Nov 13/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADAP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/06/2025 Q4 $8.8M -- -- -$0.15 --
11/13/2024 Q3 $20.5M $40.9M -$0.06 -$0.18 $0.12
08/12/2024 Q2 $44.8M $128.2M $0.24 -$0.20 $0.44
05/15/2024 Q1 $20.5M $5.7M -$0.18 -$0.20 $0.02
03/06/2024 Q4 $26M $231K -$0.18 -$0.17 -$0.01
11/08/2023 Q3 -- -- -$0.18 -$0.17 -$0.01
08/09/2023 Q2 -- -- -$0.12 -$0.18 $0.06
05/12/2023 Q1 -- -- $0.01 -$0.16 $0.16
03/06/2023 Q4 -- -- -$0.18 -$0.25 $0.07
11/08/2022 Q3 -- -- -$0.24 -$0.27 $0.03
08/04/2022 Q2 -- -- -$0.30 -$0.27 -$0.03
05/09/2022 Q1 -- -- -$0.30 -$0.26 -$0.04
03/14/2022 Q4 -- -- -$0.24 -- --
11/04/2021 Q3 -- -- -$0.30 -$0.27 -$0.04
08/09/2021 Q2 -- -- -$0.24 -$0.24 $0.00
05/06/2021 Q1 -- -- -$0.24 -$0.25 $0.01
02/25/2021 Q4 -- -- -$0.24 -- --
11/05/2020 Q3 -- -- -$0.24 -- --
08/06/2020 Q2 -- -- -$0.24 -- --
05/14/2020 Q1 -- -- -$0.24 -- --
02/27/2020 Q4 -- -- -$0.30 -- --
11/06/2019 Q3 -- -- -$0.36 -- --
08/01/2019 Q2 -- -- -$0.42 -- --
05/06/2019 Q1 -- -- -$0.24 -- --
02/27/2019 Q4 -- -- -$0.36 -- --
11/06/2018 Q3 -- -- $0.06 -- --
08/02/2018 Q2 -- -- -$0.48 -- --
05/09/2018 Q1 -- -- -$0.24 -- --
03/15/2018 Q4 -- -- -$0.30 -- --
11/02/2017 Q3 -- -- -$0.01 -- --
08/03/2017 Q2 -- -- -$0.24 -- --
03/31/2017 Q1 -- -- -$0.30 -- --
12/31/2016 Q4 -- -- -$0.24 -- --
09/30/2016 Q3 -- -- -$0.24 -- --
06/30/2016 Q2 -- -- -$0.30 -- --
03/31/2016 Q1 -- -- -$0.24 -- --
09/30/2015 Q3 -- -- -$0.02 -- --
12/31/2014 Q4 -- -- -$0.00 -- --

Adaptimmune Therapeutics PLC Earnings Questions

  • How Much did Adaptimmune Therapeutics PLC Generate in Revenue Last Quarter?

    Adaptimmune Therapeutics PLC reported $40.9M worth of top line sales in its most recent quarter.

  • Did Adaptimmune Therapeutics PLC Beat Earnings Last Quarter?

    Adaptimmune Therapeutics PLC announced earnings per share of -$0.06 which represents a beat of analyst forecast a -$0.18 per share.

  • Is Adaptimmune Therapeutics PLC Profitable?

    Adaptimmune Therapeutics PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Adaptimmune Therapeutics PLC EPS Next Year?

    Adaptimmune Therapeutics PLC's earnings are forecast to decrease from -$0.54 per share to -$0.52 per share next year representing a decrease of -71.94%.

  • When is Adaptimmune Therapeutics PLC's Earnings Date?

    Adaptimmune Therapeutics PLC's next earnings date is March 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 0.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.88% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.35% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock